CMR Surgical and LifeHealthcare have today announced an agreement to bring the next-generation Surgical Robotic System, Versius+ to Australia and New Zealand.
The partnership is set to further expand an already advanced surgical robotics market in Australia that is experiencing a 20% average annual growth in robotic procedures. Robotically assisted procedures are most commonly adopted in urology with approximately 10,000 procedures taking place robotically each year, but forecasts predict strong expansion across gynaecology and general surgery if existing barriers to robotics are addressed, including cost-effectiveness.[i]
Martin Frost, Chief Executive Officer, CMR Surgical commented: “Australia is a globally recognised centre for surgical innovation and a mature market for surgical robotics – making it a great fit for introducing Versius. By bringing a flexible, cost-effective robotic system to Australia we aim to expand the rates of minimal access surgery. To bring Versius to Australia, LifeHealthcare is a natural partner for us, with their strong record of introducing medical devices responsibly. We look forward to working closely with LifeHealthcare in this important market.”
Matt Muscio, Chief Executive Officer, LifeHealthcare commented: “We are proud to have a healthcare sector that globally leads the way in the adoption of new technology. There is strong surgical robotics expertise in Australia and significant potential to help more patients experience the benefits of minimal access surgery. With CMR’s technology, and our knowledge of the market we believe the introduction of Versius will be a real step change to the adoption of surgical robotics in Australia.”
The Versius Surgical Robotic System was awarded the European CE Mark in March 2019 and will launch in Europe shortly with an introduction into the Australian market anticipated thereafter.
For more information, please contact:
+44 (0) 7864 922341 /+44 (0) 7749 432373
+61 (0) 400 865 399
The Versius® Surgical Robotic System
Versius® resets expectations of robotic surgery by providing a versatile system that is portable, transportable and affordable. This is made possible because of its elegant form factor, modular design and individually cart-mounted arms. Versius® is able to move between operating rooms and even hospitals/clinics and gives the surgical team excellent access to the patient at all times.
Biomimicking the human arm, Versius® allows surgeons the freedom of port placement, but with the benefits of small fully-wristed instruments. With 3D HD vision, easy-to adopt instrument control and a choice of ergonomic working positions, the new open surgeon console has the potential to reduce stress and fatigue and extend the careers of surgeons.
LifeHealthcare is a leading independent provider of healthcare solutions in Australia and New Zealand bringing healthcare professionals innovative medical devices by partnering with world class companies who share the vision of innovation and making a real difference to people’s lives.
LifeHealthcare has been recognised as one of the Financial Times 1,000 High Growth Companies in Asia-Pacific. In May 2018 LifeHealthcare was acquired by Australasia’s largest private equity fund, Pacific Equity Partners, a market leader that has been recognised as a Top 20 Consistent Performer Globally by Prequin. For further information, please visit www.lifehealthcare.com.au
About CMR Surgical Limited
CMR Surgical is a British private limited company developing the next-generation robotic system, Versius®, for minimal access surgery. The company received the European CE Mark in March 2019 for the Versius® Surgical Robotic System.
The vision behind CMR Surgical is to make minimal access surgery universally accessible and affordable, transforming the existing market for surgical robotics while also addressing the six million people who still undergo open surgery each year.
Global annual revenues for robot-assisted minimal access surgery are presently approximately $4 billion and are anticipated to reach $20 billion by 2025.
CMR Surgical, formed in 2014, has its headquarters in Cambridge, United Kingdom and is backed by an international shareholder base of specialist and generalist investors.
The Company achieved the registration of its Quality Management System to ISO 13485:2016 by Underwriters Laboratories LLC® (UL), and the status as a UL Registered Firm, in September 2015.
For further information, please visit http://www.cmrsurgical.com
+This product is not currently included on the ARTG
[i] New South Wales Ministry of Health and the Victorian Department of Health and Human Services, Review of Robot-Assisted Surgery March 2019 p.20